GB9314973D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9314973D0
GB9314973D0 GB939314973A GB9314973A GB9314973D0 GB 9314973 D0 GB9314973 D0 GB 9314973D0 GB 939314973 A GB939314973 A GB 939314973A GB 9314973 A GB9314973 A GB 9314973A GB 9314973 D0 GB9314973 D0 GB 9314973D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939314973A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB939314973A priority Critical patent/GB9314973D0/en
Publication of GB9314973D0 publication Critical patent/GB9314973D0/en
Priority to JP7504909A priority patent/JPH09500383A/en
Priority to AU73858/94A priority patent/AU7385894A/en
Priority to EP94923730A priority patent/EP0710237A1/en
Priority to PCT/EP1994/002298 priority patent/WO1995003302A1/en
Priority to ZA945237A priority patent/ZA945237B/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB939314973A 1993-07-20 1993-07-20 Medicaments Pending GB9314973D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB939314973A GB9314973D0 (en) 1993-07-20 1993-07-20 Medicaments
JP7504909A JPH09500383A (en) 1993-07-20 1994-07-11 Quinolizidine having calcium channel antagonist activity
AU73858/94A AU7385894A (en) 1993-07-20 1994-07-11 Quinolizidines with calcium channel antagonistic activity
EP94923730A EP0710237A1 (en) 1993-07-20 1994-07-11 Quinolizidines with calcium channel antagonistic activity
PCT/EP1994/002298 WO1995003302A1 (en) 1993-07-20 1994-07-11 Quinolizidines with calcium channel antagonistic activity
ZA945237A ZA945237B (en) 1993-07-20 1994-07-18 Azabicyclic dericatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314973A GB9314973D0 (en) 1993-07-20 1993-07-20 Medicaments

Publications (1)

Publication Number Publication Date
GB9314973D0 true GB9314973D0 (en) 1993-09-01

Family

ID=10739088

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939314973A Pending GB9314973D0 (en) 1993-07-20 1993-07-20 Medicaments

Country Status (6)

Country Link
EP (1) EP0710237A1 (en)
JP (1) JPH09500383A (en)
AU (1) AU7385894A (en)
GB (1) GB9314973D0 (en)
WO (1) WO1995003302A1 (en)
ZA (1) ZA945237B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839898A1 (en) 1996-11-04 1998-05-06 The Procter & Gamble Company Self-thickened cleaning compositions
JP2003503500A (en) 1999-07-06 2003-01-28 バーテックス ファーマシューティカルズ インコーポレイテッド Quinuclidine derivatives for the treatment of neurological disorders
CA2422055A1 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
GB0229822D0 (en) * 2002-12-20 2003-01-29 Glaxo Group Ltd Novel compounds
US7655657B2 (en) 2003-12-22 2010-02-02 Abbott Laboratories Fused bicycloheterocycle substituted quinuclidine derivatives
US7241773B2 (en) 2003-12-22 2007-07-10 Abbott Laboratories 3-quinuclidinyl heteroatom bridged biaryl derivatives
US7160876B2 (en) 2003-12-22 2007-01-09 Abbott Laboratories Fused bicycloheterocycle substituted quinuclidine derivatives
US7309699B2 (en) 2003-12-22 2007-12-18 Abbott Laboratories 3-Quinuclidinyl amino-substituted biaryl derivatives
DE102004039789A1 (en) 2004-08-16 2006-03-02 Sanofi-Aventis Deutschland Gmbh Aryl-substituted polycyclic amines, process for their preparation and their use as pharmaceuticals

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689329A (en) * 1986-02-04 1987-08-25 Mcneilab, Inc. 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
US4716172A (en) * 1986-04-10 1987-12-29 Mcneilab, Inc. 4-substituted octahydroquinolizine analgesic compounds and octahydroquinolizinium intermediates
JPS63122682A (en) * 1986-11-13 1988-05-26 Shinichiro Sakai Indoloquinolizidine derivative
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
IE912759A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
MX9100517A (en) * 1990-08-06 1992-04-01 Smith Kline French Lab COMPOUNDS
GB9113031D0 (en) * 1991-06-17 1991-08-07 Smithkline Beecham Plc Compounds
WO1993002677A1 (en) * 1991-08-03 1993-02-18 Smithkline Beecham Plc 5-ht4 receptor antagonists
AU2491092A (en) * 1991-09-12 1993-04-05 Smithkline Beecham Plc Azabicyclic compounds as 5-ht4 receptor antagonists
WO1993008187A1 (en) * 1991-10-24 1993-04-29 Smithkline Beecham Plc Imidazopyridines and indolizines as 5-ht4 antagonists
JPH07503461A (en) * 1992-01-28 1995-04-13 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Compounds as calcium channel antagonists
GB9201751D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Plc Compounds
GB9201749D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Plc Medicaments
GB9226111D0 (en) * 1992-12-15 1993-02-10 Smithkline Beecham Plc Madicaments

Also Published As

Publication number Publication date
AU7385894A (en) 1995-02-20
ZA945237B (en) 1996-01-18
WO1995003302A1 (en) 1995-02-02
EP0710237A1 (en) 1996-05-08
JPH09500383A (en) 1997-01-14

Similar Documents

Publication Publication Date Title
GB9308430D0 (en) Medicaments
ZA93800B (en) Medicaments
GB9201749D0 (en) Medicaments
GB9216380D0 (en) Medicaments
GB9315566D0 (en) Medicaments
GB9313574D0 (en) Medicaments
GB9314973D0 (en) Medicaments
GB9224739D0 (en) Medicaments
GB9202522D0 (en) Medicaments
GB9313649D0 (en) Medicaments
GB9325335D0 (en) Medicaments
GB9321194D0 (en) Medicaments
GB9304021D0 (en) Medicaments
GB9304010D0 (en) Medicaments
GB9303188D0 (en) Medicaments
GB9205139D0 (en) Medicaments
GB9216857D0 (en) Medicaments
GB9204151D0 (en) Medicaments
GB9202521D0 (en) Medicaments
GB9205980D0 (en) Medicaments
GB9206083D0 (en) Medicaments
GB9207590D0 (en) Medicaments
GB9210306D0 (en) Medicaments
GB9211802D0 (en) Medicaments
GB9211803D0 (en) Medicaments